— Know what they know.
Not Investment Advice

GENI NYSE

Genius Sports Limited
1W: +17.3% 1M: +8.4% 3M: -20.1% YTD: -54.7% 1Y: -50.9% 3Y: -0.6% 5Y: -73.4%
$5.35
+0.46 (+9.41%)
 
Weekly Expected Move ±8.2%
$4 $4 $4 $5 $5
NYSE · Communication Services · Internet Content & Information · Alpha Radar Buy · Power 57 · $1.4B mcap · 232M float · 2.77% daily turnover · Short 45% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.2 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -23.9%  ·  5Y Avg: -45.1%
Cost Advantage ★
41
Intangibles
30
Switching Cost
41
Network Effect
28
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GENI has No discernible competitive edge (36.2/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -23.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$9
Low
$10
Avg Target
$10
High
Based on 4 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$9.57
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-11 Deutsche Bank Steven Pizzella Initiated $10 +132.8% $4.29
2026-05-08 Needham Bernie McTernan $13 $10 -3 +116.2% $4.62
2026-05-08 Roth Capital Initiated $10 +116.2% $4.62
2026-05-08 BTIG $16 $9 -7 +88.3% $4.78
2026-04-21 Truist Financial $13 $10 -3 +107.3% $4.83
2026-04-09 Stifel Nicolaus $7 $5 -2 +22.9% $4.07
2026-03-04 Truist Financial Barry Jones $15 $13 -2 +115.2% $6.04
2026-02-19 Stifel Nicolaus Jeffrey Stantial $10 $7 -3 +11.5% $6.28
2026-02-18 UBS $16 $6 -10 +3.6% $5.79
2026-02-09 Wells Fargo $16 $10 -6 +64.2% $6.09
2026-02-06 Northland Securities Initiated $12 +92.0% $6.25
2026-02-06 Oppenheimer Initiated $12 +93.9% $6.19
2026-02-02 Truist Financial Barry Jones Initiated $15 +73.7% $8.63
2026-01-21 Stifel Nicolaus Jeffrey Stantial Initiated $10 +2.8% $9.73
2026-01-09 Wells Fargo Initiated $16 +51.8% $10.54
2025-12-08 UBS $13 $16 +3 +48.6% $10.77
2025-12-04 Guggenheim $16 $17 +1 +50.2% $11.32
2025-12-04 BTIG Clark Lampen Initiated $16 +41.3% $11.32
2025-12-04 Goldman Sachs $8 $16 +8 +41.3% $11.32
2025-12-04 New Street Initiated $17 +50.2% $11.32
2025-09-10 UBS Initiated $13 +3.5% $12.56
2025-09-03 JMP Securities Jordan Bender $13 $15 +2 +14.9% $13.06
2025-08-07 Guggenheim Curry Baker Initiated $16 +33.8% $11.96
2025-06-30 JMP Securities Jordan Bender Initiated $13 +25.0% $10.40
2025-03-05 Needham $7 $13 +6 +33.7% $9.72
2025-03-04 Craig-Hallum Initiated $15 +61.1% $9.31
2024-04-15 Goldman Sachs Ben Miller Initiated $8 +45.6% $5.15
2024-04-05 B.Riley Financial David Bain Initiated $9 +56.3% $5.76
2023-03-13 Needham Bernie McTernan $6 $7 +1 +64.5% $4.25
2022-05-13 Needham Initiated $6 +112.8% $2.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
4
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GENI receives an overall rating of C. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-08 C- C
2026-04-21 D+ C-
2026-04-13 C- D+
2026-04-10 D+ C-
2026-04-01 C- D+
2026-03-16 C C-
2026-03-05 C- C
2026-02-10 C C-
2026-02-09 C- C
2026-01-13 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

25 Grade D
Profitability
7
Balance Sheet
0
Earnings Quality
18
Growth
52
Value
31
Momentum
50
Safety
15
Cash Flow
35
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GENI scores highest in Growth (52/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.65
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.91
Unlikely Manipulator
Ohlson O-Score
-7.18
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB
Score: 44.2/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.34x
Accruals: -22.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GENI scores 0.65, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GENI scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GENI's score of -2.91 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GENI's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GENI receives an estimated rating of BB (score: 44.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-9.06x
PEG
0.10x
P/S
1.93x
P/B
2.07x
P/FCF
71.97x
P/OCF
21.98x
EV/EBITDA
-11.25x
EV/Revenue
1.32x
EV/EBIT
-5.91x
EV/FCF
56.89x
Earnings Yield
-13.31%
FCF Yield
1.39%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GENI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.981
NI / EBT
×
Interest Burden
1.015
EBT / EBIT
×
EBIT Margin
-0.224
EBIT / Rev
×
Asset Turnover
0.742
Rev / Assets
×
Equity Multiplier
1.482
Assets / Equity
=
ROE
-24.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GENI's ROE of -24.5% is driven by Asset Turnover (0.742), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1415 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.36
Median 1Y
$3.77
5th Pctile
$1.12
95th Pctile
$12.72
Ann. Volatility
70.0%
Analyst Target
$9.57
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,700
+17.4% YoY
Revenue / Employee
$247,959
Rev: $669,489,000
Profit / Employee
$-41,326
NI: $-111,581,000
SGA / Employee
$84,203
Avg labor cost proxy
R&D / Employee
$11,514
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -2.3% -2.6% -1.3% -1.4% -36.7% -23.4% -28.3% -26.0% -26.8% -27.2% -14.9% -14.9% -16.9% -12.7% -11.0% -8.0% -13.6% -20.8% -17.2% -24.5% -24.50%
ROA -1.2% -1.4% -92.8% -98.2% -26.3% -16.8% -21.9% -20.1% -20.7% -21.1% -11.0% -11.1% -12.6% -9.5% -8.0% -5.8% -9.9% -15.2% -11.6% -16.5% -16.53%
ROIC -1.2% -1.4% -93.6% -1.0% -40.1% -35.0% -30.4% -23.4% -18.1% -14.1% -12.0% -12.2% -14.4% -13.9% -9.8% -9.2% -19.2% -20.5% -22.4% -23.9% -23.94%
ROCE -1.5% -1.8% -88.6% -93.5% -35.8% -30.8% -39.8% -37.0% -31.6% -27.4% -12.1% -12.4% -14.4% -14.0% -9.5% -8.8% -18.9% -23.2% -19.3% -20.5% -20.54%
Gross Margin -3.3% -25.0% -30.2% -18.0% 13.1% 7.4% 3.0% 9.8% 28.4% 23.9% 8.3% 10.7% 29.7% 33.3% 27.0% 24.4% 7.5% 24.7% 28.5% 22.9% 22.87%
Operating Margin -7.7% -93.7% -90.8% -75.7% -55.8% -42.4% -42.5% -23.7% -9.0% -8.7% -27.0% -20.3% -22.0% -5.0% -4.1% -14.2% -68.0% -8.0% -8.4% -15.8% -15.76%
Net Margin -8.3% -1.0% -63.4% -46.8% -6.7% -11.4% -1.2% -25.9% -11.9% -11.4% -30.2% -21.3% -22.8% 10.4% -16.1% -5.7% -45.4% -17.3% -8.6% -29.5% -29.51%
EBITDA Margin -8.1% -73.4% -1.1% -25.3% -31.5% -21.2% -1.0% -5.0% 12.0% 9.8% -7.7% -2.2% 1.4% 8.1% 4.5% -2.3% -53.4% -7.3% -0.0% -4.4% -4.42%
FCF Margin -14.1% -29.7% -36.8% -45.0% -28.1% -17.7% -15.0% -12.3% -19.0% -14.2% -8.3% -7.4% -4.2% -9.0% 3.4% -0.7% -3.6% 3.7% 5.5% 2.3% 2.32%
OCF Margin -16.7% -26.7% -24.1% -31.2% -12.6% -2.5% -1.1% 0.8% -6.5% -1.9% 3.6% 4.4% 8.2% 4.2% 16.0% 12.3% 9.5% 13.9% 12.9% 7.6% 7.61%
ROE 3Y Avg snapshot only -14.97%
ROE 5Y Avg snapshot only -32.53%
ROA 3Y Avg snapshot only -10.30%
ROIC 3Y Avg snapshot only -17.87%
ROIC Economic snapshot only -15.33%
Cash ROA snapshot only 4.80%
Cash ROIC snapshot only 11.45%
CROIC snapshot only 3.50%
NOPAT Margin snapshot only -15.92%
Pretax Margin snapshot only -22.70%
R&D / Revenue snapshot only 4.70%
SGA / Revenue snapshot only 37.77%
SBC / Revenue snapshot only 15.47%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -5.86 -6.37 -2.46 -1.43 -2.65 -6.85 -3.96 -6.16 -7.50 -6.37 -16.44 -15.24 -12.84 -25.01 -31.51 -54.42 -33.83 -26.77 -25.64 -7.51 -9.055
P/S Ratio 18.08 15.61 5.56 3.05 1.44 2.30 2.11 2.91 3.51 2.84 3.40 3.01 2.82 3.96 3.89 4.65 4.72 5.28 4.27 1.67 1.928
P/B Ratio 13.40 16.68 2.07 1.28 0.63 1.04 1.25 1.78 2.24 1.93 2.45 2.29 2.18 3.20 3.47 4.34 4.60 5.57 3.95 1.65 2.069
P/FCF -128.07 -52.63 -15.10 -6.79 -5.12 -12.99 -14.06 -23.68 -18.43 -20.04 -41.03 -40.78 -66.81 -43.92 112.84 -673.57 -130.47 142.02 78.28 71.97 71.969
P/OCF 354.47 94.50 68.47 34.35 95.18 24.27 37.88 49.43 37.94 33.11 21.98 21.976
EV/EBITDA -6.61 -7.34 -2.09 -1.09 -1.17 -3.26 -3.61 -5.99 -9.78 -10.65 233.91 155.66 -1011.24 -1265.81 115.71 152.23 -51.58 -43.51 -33.10 -11.25 -11.247
EV/Revenue 18.60 15.97 4.71 2.30 0.72 1.60 1.81 2.63 3.23 2.59 3.20 2.81 2.62 3.78 3.69 4.45 4.53 5.11 3.90 1.32 1.322
EV/EBIT -6.16 -6.64 -1.90 -0.99 -0.85 -2.27 -2.58 -4.16 -6.25 -6.13 -18.42 -16.70 -13.66 -21.08 -33.47 -45.70 -22.71 -22.52 -17.44 -5.91 -5.909
EV/FCF -131.75 -53.84 -12.81 -5.11 -2.57 -9.06 -12.08 -21.34 -16.98 -18.21 -38.53 -38.11 -62.23 -41.87 107.00 -645.75 -125.39 137.44 71.44 56.89 56.888
Earnings Yield -17.1% -15.7% -40.6% -69.7% -37.7% -14.6% -25.3% -16.2% -13.3% -15.7% -6.1% -6.6% -7.8% -4.0% -3.2% -1.8% -3.0% -3.7% -3.9% -13.3% -13.31%
FCF Yield -0.8% -1.9% -6.6% -14.7% -19.5% -7.7% -7.1% -4.2% -5.4% -5.0% -2.4% -2.5% -1.5% -2.3% 0.9% -0.1% -0.8% 0.7% 1.3% 1.4% 1.39%
PEG Ratio snapshot only 0.102
Price/Tangible Book snapshot only 4.927
EV/OCF snapshot only 17.371
EV/Gross Profit snapshot only 5.848
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.72 0.72 2.12 2.12 2.12 2.12 1.38 1.38 1.38 1.38 1.34 1.34 1.34 1.34 1.43 1.43 1.43 1.43 1.56 1.56 1.558
Quick Ratio 0.71 0.71 2.12 2.12 2.12 2.12 1.38 1.38 1.38 1.38 1.34 1.34 1.34 1.34 1.43 1.43 1.43 1.43 1.56 1.56 1.557
Debt/Equity 0.44 0.44 0.00 0.00 0.00 0.00 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.04 0.04 0.042
Net Debt/Equity 0.38 0.38 -0.31 -0.31 -0.31 -0.31 -0.18 -0.18 -0.18 -0.18 -0.15 -0.15 -0.15 -0.15 -0.18 -0.18 -0.18 -0.18 -0.35 -0.35 -0.345
Debt/Assets 0.24 0.24 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.03 0.03 0.027
Debt/EBITDA -0.21 -0.19 -0.00 -0.00 -0.00 -0.00 -0.12 -0.14 -0.17 -0.22 2.61 1.87 -12.76 -10.65 0.46 0.48 -0.15 -0.11 -0.39 -0.36 -0.364
Net Debt/EBITDA -0.18 -0.17 0.38 0.36 1.16 1.41 0.59 0.66 0.83 1.07 -15.17 -10.89 74.33 62.05 -6.31 -6.56 2.09 1.45 3.17 2.98 2.982
Interest Coverage -92.98 -103.25 -195.27 -499.23 -241.96 -176.75 -161.23 -203.21 -206.26 -296.90 -354.77 -362.75 -6374.69 -4330.08 -4013.00 -8571.77 -993.31 -149.86 -82.84 -82.845
Equity Multiplier 1.85 1.85 1.26 1.26 1.26 1.26 1.34 1.34 1.34 1.34 1.35 1.35 1.35 1.35 1.38 1.38 1.38 1.38 1.56 1.56 1.560
Cash Ratio snapshot only 0.795
Debt Service Coverage snapshot only -43.524
Cash to Debt snapshot only 9.200
FCF to Debt snapshot only 0.544
Defensive Interval snapshot only 560.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.40 0.58 0.41 0.46 0.49 0.50 0.41 0.42 0.44 0.47 0.53 0.56 0.57 0.60 0.65 0.68 0.71 0.77 0.70 0.74 0.742
Inventory Turnover 819.57 1044.67 1041.94 1176.00 785.68 755.88 831.90 798.25 799.12 810.50 1091.97 1152.97 1168.55 1177.02 922.04 926.57 1029.72 1138.71 1347.20 1441.66 1441.658
Receivables Turnover 4.49 6.47 6.28 7.05 7.41 7.64 8.30 8.57 8.96 9.52 7.91 8.34 8.50 8.86 5.46 5.72 5.97 6.46 5.43 5.79 5.790
Payables Turnover 31.14 39.69 31.76 35.84 23.95 23.04 12.76 12.24 12.26 12.43 7.60 8.03 8.13 8.19 8.13 8.17 9.08 10.04 6.93 7.42 7.416
DSO 81 56 58 52 49 48 44 43 41 38 46 44 43 41 67 64 61 57 67 63 63.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 days
DPO 12 9 11 10 15 16 29 30 30 29 48 45 45 45 45 45 40 36 53 49 49.2 days
Cash Conversion Cycle 70 48 47 42 34 32 16 13 11 9 -2 -1 -2 -3 22 20 21 20 15 14 14.1 days
Fixed Asset Turnover snapshot only 11.765
Operating Cycle snapshot only 63.3 days
Cash Velocity snapshot only 2.543
Capital Intensity snapshot only 1.584
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.6% 1.9% 98.1% 41.6% 29.8% 19.5% 18.7% 22.3% 21.1% 23.6% 20.6% 18.3% 23.7% 22.9% 25.8% 30.7% 31.0% 33.3% 33.31%
Net Income -42.9% -32.3% 65.2% 80.6% 69.4% 73.5% -2.3% -63.0% 52.9% 48.4% 43.4% 58.1% 26.3% 46.8% 20.1% -62.6% -77.0% -2.5% -2.48%
EPS -39.8% -29.4% 73.5% 81.7% 70.8% 74.8% 2.6% -56.3% 58.3% 53.6% 48.6% 62.6% 27.0% 50.9% 27.6% -47.5% -56.6% -2.2% -2.21%
FCF -8.1% -11.5% -2.9% 15.6% 47.1% 67.3% 19.7% 1.8% 33.0% 26.0% 73.3% 24.9% 1.5% 88.5% -7.8% 1.5% 1.1% 5.5% 5.49%
EBITDA -185.9% -62.3% 56.6% 68.0% 71.0% 75.1% 36.5% 39.6% 1.0% 1.1% 99.1% 98.5% 1.9% 99.2% -41.6% -50.4% -5.8% -6.4% -6.36%
Op. Income -80.1% -61.6% 44.0% 57.5% 68.1% 77.8% 55.6% 60.5% 59.4% 46.5% 18.8% -1.4% 21.1% 27.5% -29.1% -41.9% -1.3% -1.6% -1.63%
OCF Growth snapshot only -17.30%
Asset Growth snapshot only 42.67%
Equity Growth snapshot only 26.57%
Debt Growth snapshot only 3.06%
Shares Change snapshot only 8.43%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.1% 62.9% 41.5% 27.0% 24.8% 22.0% 21.7% 23.7% 25.2% 26.5% 26.51%
Revenue 5Y 70.1% 47.9% 47.92%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y 20.9% -8.0%
EBITDA 5Y
Gross Profit 3Y 76.2% 40.2% 2.8% 79.6% 79.59%
Gross Profit 5Y 64.9% 43.8% 43.80%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y 21.8% 5.5% 5.51%
OCF 3Y 2.2% 72.2% 1.7% 1.66%
OCF 5Y 1.9% 70.7% 70.69%
Assets 3Y 25.7% 25.7% 25.7% 25.7% -3.7% -3.7% -3.7% -3.7% 13.5% 13.5% 13.49%
Assets 5Y 23.7% 23.7% 23.65%
Equity 3Y 39.5% 39.5% 39.5% 39.5% -6.8% -6.8% -6.8% -6.8% 7.9% 7.9% 7.89%
Book Value 3Y 28.7% 28.3% 21.3% 29.9% -12.1% -13.9% -14.1% -14.3% -0.9% -1.3% -1.30%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.93 0.91 0.94 0.99 0.92 0.93 0.95 1.00 1.00 0.99 0.98 0.97 0.99 0.99 0.988
Earnings Stability 0.08 0.05 0.74 0.62 0.01 0.01 0.75 0.64 0.08 0.09 0.72 0.52 0.09 0.07 0.071
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.43 0.60 0.596
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
Earnings Persistence 0.50 0.50 0.99 0.50 0.50 0.81 0.83 0.50 0.89 0.81 0.92 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.14 0.20 0.96 1.08 0.43 0.44 0.10 0.10 0.12 0.14 0.10 0.01 -0.02 -0.10 -0.104
Gross Margin Trend 0.28 0.36 0.70 0.59 0.57 0.54 0.19 0.16 0.16 0.16 0.09 0.04 0.02 0.00 0.002
FCF Margin Trend -0.11 0.04 0.02 0.09 0.18 0.21 0.19 0.07 0.15 0.09 0.08 0.15 0.08 0.06 0.064
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.05 0.11 0.11 0.15 0.23 0.07 0.02 -0.02 0.14 0.04 -0.17 -0.22 -0.37 -0.26 -1.30 -1.44 -0.68 -0.71 -0.77 -0.34 -0.342
FCF/OCF 0.85 1.11 1.53 1.44 2.23 7.18 14.25 -14.97 2.92 7.43 -2.30 -1.68 -0.51 -2.17 0.22 -0.06 -0.38 0.27 0.42 0.31 0.305
FCF/Net Income snapshot only -0.104
CapEx/Revenue 2.6% 3.0% 12.7% 13.8% 15.5% 15.2% 13.9% 13.1% 12.5% 12.3% 11.9% 11.8% 12.4% 13.2% 12.6% 13.0% 13.2% 10.2% 7.4% 5.3% 5.29%
CapEx/Depreciation snapshot only 0.498
Accruals Ratio -1.17 -1.26 -0.83 -0.84 -0.20 -0.16 -0.21 -0.20 -0.18 -0.20 -0.13 -0.14 -0.17 -0.12 -0.18 -0.14 -0.17 -0.26 -0.21 -0.22 -0.222
Sloan Accruals snapshot only 0.035
Cash Flow Adequacy snapshot only 1.440
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -0.5% -1.2% -1.9% -3.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.8% -5.5% -4.5% -5.0% 0.0% 0.00%
Total Shareholder Return 0.0% -0.5% -1.2% -1.9% -3.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.8% -5.5% -4.5% -5.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.01 1.01 0.98 0.98 0.94 0.91 1.01 1.01 1.03 1.04 1.07 1.07 1.01 1.06 1.01 1.00 1.04 0.97 0.98 0.98 0.981
Interest Burden (EBT/EBIT) 1.01 1.01 0.93 0.93 0.68 0.52 0.75 0.74 0.87 1.02 1.12 1.09 1.14 0.84 1.11 0.88 0.67 0.90 0.76 1.01 1.015
EBIT Margin -3.02 -2.41 -2.48 -2.33 -0.85 -0.71 -0.70 -0.63 -0.52 -0.42 -0.17 -0.17 -0.19 -0.18 -0.11 -0.10 -0.20 -0.23 -0.22 -0.22 -0.224
Asset Turnover 0.40 0.58 0.41 0.46 0.49 0.50 0.41 0.42 0.44 0.47 0.53 0.56 0.57 0.60 0.65 0.68 0.71 0.77 0.70 0.74 0.742
Equity Multiplier 1.85 1.85 1.39 1.39 1.39 1.39 1.29 1.29 1.29 1.29 1.35 1.35 1.35 1.35 1.37 1.37 1.37 1.37 1.48 1.48 1.482
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-3.20 $-2.93 $-3.09 $-3.21 $-0.85 $-0.54 $-0.90 $-0.81 $-0.83 $-0.84 $-0.38 $-0.37 $-0.42 $-0.31 $-0.27 $-0.18 $-0.31 $-0.46 $-0.43 $-0.59 $-0.59
Book Value/Share $1.40 $1.12 $3.68 $3.61 $3.56 $3.53 $2.86 $2.80 $2.77 $2.76 $2.52 $2.50 $2.50 $2.45 $2.49 $2.30 $2.26 $2.22 $2.79 $2.69 $2.58
Tangible Book/Share $-0.69 $-0.55 $0.88 $0.86 $0.85 $0.84 $0.58 $0.57 $0.56 $0.56 $0.52 $0.51 $0.51 $0.50 $0.57 $0.53 $0.52 $0.51 $0.93 $0.90 $0.90
Revenue/Share $1.04 $1.20 $1.37 $1.51 $1.56 $1.60 $1.69 $1.71 $1.77 $1.87 $1.82 $1.90 $1.94 $1.98 $2.22 $2.15 $2.21 $2.35 $2.58 $2.65 $2.65
FCF/Share $-0.15 $-0.35 $-0.50 $-0.68 $-0.44 $-0.28 $-0.25 $-0.21 $-0.34 $-0.27 $-0.15 $-0.14 $-0.08 $-0.18 $0.08 $-0.01 $-0.08 $0.09 $0.14 $0.06 $0.06
OCF/Share $-0.17 $-0.32 $-0.33 $-0.47 $-0.20 $-0.04 $-0.02 $0.01 $-0.12 $-0.04 $0.07 $0.08 $0.16 $0.08 $0.36 $0.26 $0.21 $0.33 $0.33 $0.20 $0.20
Cash/Share $0.08 $0.06 $1.16 $1.14 $1.12 $1.11 $0.61 $0.60 $0.59 $0.59 $0.44 $0.44 $0.44 $0.43 $0.48 $0.44 $0.44 $0.43 $1.08 $1.04 $0.73
EBITDA/Share $-2.92 $-2.60 $-3.08 $-3.17 $-0.96 $-0.79 $-0.85 $-0.75 $-0.58 $-0.45 $0.02 $0.03 $-0.01 $-0.01 $0.07 $0.06 $-0.19 $-0.28 $-0.30 $-0.31 $-0.31
Debt/Share $0.62 $0.49 $0.00 $0.00 $0.00 $0.00 $0.11 $0.10 $0.10 $0.10 $0.06 $0.06 $0.06 $0.06 $0.03 $0.03 $0.03 $0.03 $0.12 $0.11 $0.11
Net Debt/Share $0.54 $0.43 $-1.16 $-1.14 $-1.12 $-1.11 $-0.50 $-0.49 $-0.49 $-0.49 $-0.38 $-0.37 $-0.37 $-0.37 $-0.45 $-0.41 $-0.41 $-0.40 $-0.96 $-0.93 $-0.93
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.653
Altman Z-Prime snapshot only -0.178
Piotroski F-Score 2 2 4 4 6 5 4 5 3 3 6 6 6 6 7 7 6 5 6 5 5
Beneish M-Score -5.37 -5.79 -15.86 -4.20 -9.34 -4.97 -3.60 -3.80 -2.90 -2.68 -2.88 -2.76 -3.60 -3.44 -1.73 -3.37 -2.93 -2.91 -2.912
Ohlson O-Score snapshot only -7.178
ROIC (Greenblatt) snapshot only -62.01%
Net-Net WC snapshot only $0.53
EVA snapshot only $-161017030.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 48.24 48.89 38.85 30.57 30.18 35.49 30.53 32.20 41.57 35.55 47.50 43.84 55.13 57.17 68.81 59.24 59.50 68.80 62.86 44.18 44.177
Credit Grade snapshot only 12
Credit Trend snapshot only -15.064
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 34
Sector Credit Rank snapshot only 41

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms